Leslie Ochs

760 total citations
17 papers, 575 citations indexed

About

Leslie Ochs is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology. According to data from OpenAlex, Leslie Ochs has authored 17 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Geriatrics and Gerontology. Recurrent topics in Leslie Ochs's work include Opioid Use Disorder Treatment (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Prenatal Substance Exposure Effects (3 papers). Leslie Ochs is often cited by papers focused on Opioid Use Disorder Treatment (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Prenatal Substance Exposure Effects (3 papers). Leslie Ochs collaborates with scholars based in United States and Canada. Leslie Ochs's co-authors include Jordan R. Covvey, Kirk E. Evoy, Alyssa M. Peckham, Rowan T. Chlebowski, Aaron K. Aragaki, Nananda F. Col, Robert M. Goodman, Robert F. Valois, Abraham Wandersman and Heather Stewart and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Public Health and Breast Cancer Research and Treatment.

In The Last Decade

Leslie Ochs

17 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Ochs United States 10 198 142 99 95 75 17 575
Antonio Pascual Spain 16 399 2.0× 108 0.8× 222 2.2× 204 2.1× 130 1.7× 46 1.0k
Camilla B. Pimentel United States 13 164 0.8× 70 0.5× 246 2.5× 54 0.6× 20 0.3× 30 530
Cheryl Craigs United Kingdom 13 184 0.9× 19 0.1× 125 1.3× 132 1.4× 96 1.3× 20 578
Mei You United States 16 102 0.5× 60 0.4× 89 0.9× 229 2.4× 158 2.1× 36 681
Loredana Buonaccorso Italy 9 201 1.0× 41 0.3× 34 0.3× 136 1.4× 131 1.7× 23 576
Raylene M. Rospond United States 11 222 1.1× 19 0.1× 116 1.2× 143 1.5× 83 1.1× 22 951
Roger Hunt Australia 13 621 3.1× 34 0.2× 284 2.9× 169 1.8× 230 3.1× 29 1.0k
Chen Hsiu Chen Taiwan 10 308 1.6× 27 0.2× 119 1.2× 117 1.2× 141 1.9× 17 460
Sarah White United States 16 335 1.7× 51 0.4× 156 1.6× 34 0.4× 132 1.8× 51 851
Li‐Chi Huang Taiwan 18 162 0.8× 97 0.7× 177 1.8× 29 0.3× 224 3.0× 48 757

Countries citing papers authored by Leslie Ochs

Since Specialization
Citations

This map shows the geographic impact of Leslie Ochs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Ochs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Ochs more than expected).

Fields of papers citing papers by Leslie Ochs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Ochs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Ochs. The network helps show where Leslie Ochs may publish in the future.

Co-authorship network of co-authors of Leslie Ochs

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Ochs. A scholar is included among the top collaborators of Leslie Ochs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Ochs. Leslie Ochs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Garber, Sarah S., et al.. (2023). Utilizing video simulation in interprofessional education to teach IPEC competencies and social determinants of health: A universal IPE teaching tool. Journal of Interprofessional Education & Practice. 31. 100617–100617. 3 indexed citations
2.
Evoy, Kirk E., Laura Roccograndi, Charles E. Leonard, et al.. (2020). National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016. Journal of Substance Abuse Treatment. 119. 108141–108141. 4 indexed citations
3.
Evoy, Kirk E., Charles E. Leonard, Jordan R. Covvey, et al.. (2020). Receipt of Substance Use Counseling Among Ambulatory Patients Prescribed Opioids in the United States. Substance Abuse Research and Treatment. 14. 621452092–621452092. 3 indexed citations
4.
Aparasu, Rajender R., Kathleen M.K. Boje, Jennifer Danielson, et al.. (2019). Consideration of Aggressive and Strategic Approaches to Address Declining Enrollment in US Pharmacy Schools. American Journal of Pharmaceutical Education. 83(6). 6959–6959. 29 indexed citations
5.
Evoy, Kirk E., et al.. (2018). Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS). Research in Social and Administrative Pharmacy. 15(8). 953–958. 74 indexed citations
6.
Peckham, Alyssa M., Kirk E. Evoy, Leslie Ochs, & Jordan R. Covvey. (2018). Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?. Substance Abuse Research and Treatment. 12. 620358815–620358815. 75 indexed citations
7.
Peckham, Alyssa M., Kirk E. Evoy, Jordan R. Covvey, et al.. (2018). Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 38(4). 436–443. 38 indexed citations
8.
Mager, Natalie A. DiPietro, et al.. (2017). Partners in Public Health: Public Health Collaborations With Schools of Pharmacy, 2015. Public Health Reports. 132(3). 298–303. 4 indexed citations
9.
Stewart, Heather, et al.. (2017). Multi-state medication take back initiative: Controlled substances collected from 2011 to 2015. Journal of Substance Use. 23(1). 36–42. 10 indexed citations
10.
Ratka, Anna, Toyin Tofade, Patricia R. Wigle, et al.. (2016). Current Practices in Global/International Advanced Pharmacy Practice Experiences: Preceptor and Student Considerations. American Journal of Pharmaceutical Education. 80(3). 39–39. 31 indexed citations
11.
McCall, Kenneth L., et al.. (2016). Prescription Monitoring Program Trends Among Individuals Arrested in Maine for Trafficking Prescription Drugs in 2014. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(6). 585–589. 8 indexed citations
12.
Stewart, Heather, et al.. (2014). Inside Maine’s Medicine Cabinet: Findings From the Drug Enforcement Administration's Medication Take-Back Events. American Journal of Public Health. 105(1). e65–e71. 35 indexed citations
13.
14.
Col, Nananda F., et al.. (2012). Metformin and breast cancer risk: a meta-analysis and critical literature review. Breast Cancer Research and Treatment. 135(3). 639–646. 160 indexed citations
15.
Col, Nananda F., et al.. (2012). Metformin and breast cancer risk: A meta-analysis and critical literature review.. Journal of Clinical Oncology. 30(27_suppl). 25–25. 3 indexed citations
16.
Corwin, Sara J., Kathryn A. Frahm, Leslie Ochs, et al.. (2006). Medical Student and Senior Participants' Perceptions of a Mentoring Program Designed to Enhance Geriatric Medical Education. Gerontology & Geriatrics Education. 26(3). 47–65. 33 indexed citations
17.
Wandersman, Abraham, et al.. (1996). Toward a Social Ecology of Community Coalitions. American Journal of Health Promotion. 10(4). 299–307. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026